Download presentation
Presentation is loading. Please wait.
Published byWillis Logan Modified over 6 years ago
1
ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma
Oncology - DOI: / Fig. 1. The immunohistochemical analysis of ZNF750 expression in ESCC. a Images for high expression (A and C) and low expression (B and D) are shown (×100 in the upper section, ×400 in the lower section). b A comparison of the overall survival of high- and low-ZNF750 expression groups of ESCC patients. ESCC, esophageal squamous cell carcinoma. © 2017 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4.0
2
ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma
Oncology - DOI: / Fig. 2. The effects of ZNF750 knockdown on ESCC cell proliferation, migration, and invasion. ESCC cell lines (TE8 and TE11) were transfected with control siRNA or 2 siRNAs (siZNF750-1 and siZNF750-2). a ZNF750 expression in ESCC cell lines after transfection of siZNF750. b Results of the proliferation assay. c Results of the migration/invasion assay. d Results of the apoptosis assay. * p < ESCC, esophageal squamous cell carcinoma. © 2017 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4.0
3
ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma
Oncology - DOI: / Table 1. Patient characteristics (n = 124) © 2017 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4.0
4
ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma
Oncology - DOI: / Table 2. Relation between ZNF750 expression and clinicopathological characteristics © 2017 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4.0
5
ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma
Oncology - DOI: / Table 3. Univariate and multivariate analysis of clinicopathological factors and overall survival in ESCC © 2017 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4.0
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.